Literature DB >> 1628286

Percutaneous fenestration of a type I aortic dissection for relief of lower extremity ischemia.

M H Faykus1, P Hiette, R Koopot.   

Abstract

A 36-year-old patient underwent successful percutaneous fenestration of a type I aortic dissection which had caused occlusion of the right common iliac artery and ischemia of the right lower extremity. The patient is currently (6 months post-fenestration) ambulating without any signs of vascular compromise. The technique may be useful in patients who are at high risk for surgical procedures.

Entities:  

Mesh:

Year:  1992        PMID: 1628286     DOI: 10.1007/bf02735585

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  Relief of mesenteric ischemia in type III aortic dissection with percutaneous fenestration of the aortic septum.

Authors:  D M Williams; T E Brothers; L M Messina
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

2.  Independent determinants of operative mortality for patients with aortic dissections.

Authors:  D C Miller; R S Mitchell; P E Oyer; E B Stinson; S W Jamieson; N E Shumway
Journal:  Circulation       Date:  1984-09       Impact factor: 29.690

3.  Dissecting hematoma presents as acute lower limb ischemia: diagnostic patient profile and management.

Authors:  P M Shah; R H Clauss
Journal:  J Cardiovasc Surg (Torino)       Date:  1983 Nov-Dec       Impact factor: 1.888

4.  Aortic dissection manifested as leg ischemia.

Authors:  T J White; M L Pinstein; R L Scott; R E Gold
Journal:  AJR Am J Roentgenol       Date:  1980-08       Impact factor: 3.959

  4 in total
  2 in total

1.  [Postoperative compartment syndrome in a patient with acute aortic dissection (DeBakey type I)].

Authors:  T Yamamoto; H Makuuchi; Y Naruse; T Kobayashi; M Goto; K Nonaka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-11

Review 2.  Endoluminal treatment of aortic dissection.

Authors:  Ajay Chavan; Joachim Lotz; Frank Oelert; Michael Galanski; Axel Haverich; Matthias Karck
Journal:  Eur Radiol       Date:  2003-06-17       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.